{"ticker": {"uuid": "e87c6c84-6543-4e8d-a4d7-16d69b27cf09", "symbol": "600594", "name": "Guizhou Yibai Pharmaceutical Co., Ltd.", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Global Penny Stocks: Guizhou Yibai Pharmaceutical And 2 More To Watch", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-16T09:15:54+00:00", "published_display": "16 Jul 2026 09:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yibai Pharmaceutical reported revenue of 1.863 billion yuan in 2025, a year-on-year decrease of 14.31%. The company incurred a net loss attributable to shareholders of 330 million yuan, while the gross profit margin increased to 59.65%.", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOMG1XN0hTM2FiVVpXU2U5OGMxVUN1bTg0TUdSQ0VCTGxHck5wbm1XTDZjOFZ1UjdZdzdzMEVlczNVRU50WjN4ekxfR1J2VlY2Uno4NFZFd0pzeG0tekdWX3lBaUZJdWZFNWpOa2FuTU01MFYzMndkY0o1TmgxelBDTG5pS2ROZjl1OFJmenpfWGp6RFB4N3laM3JEbENDYWk5Q0Via1ZB?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-15T00:37:16+00:00", "published_display": "15 Jul 2026 00:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EBIT per share of Guizhou Yibai Pharmaceutical Co. Ltd. Class A \u2013 SSE:600594", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQV0cyS3VNV1Bkell3b3NQY3daT2FlazNIVlRaV1hxaWVZSmIzNU1zOVFCWm83U3IySEV2S05aUmNVRmMzMG92NnA1cFpWTkZuWTFSTnl6blBMU1ZXUzFOUDdnWVl3MnlkR3JVcDlOZ0gtTjhmNGVuMENKSmRvSVRWZGRwX0EyYVRCZ3NLU2ExTnhBd01EZEhnVVdlQQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-08T14:10:43+00:00", "published_display": "08 Jul 2026 14:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guizhou Yibai Pharmaceutical Co.,Ltd.\u2019s Net Profit Dropped 26.9% in First Quarter of 2022", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNRDI0RmluM192a2FGd3dER2ZYWGRKSVg0RThTTE1laTNiYkdnS0xjTVpmNEpsb3VMVXJMd1lPSTdvdXM1eEhNVERrUzNWREhSMHlKWU4xaXlyZ21yZERCaHQwaGd2RmtlVzhmU05SV0JiUHNHSDBvOHJCWm1JVlZOY2tjRkJabTUyZ3prWV94TW01U3V1bWt6VDBXeDg1SjFEUngtQmt5a2MwaUlYaU5JTmxZUm9EU2o1WmFyV2s1V1RGRWhETXA2ZEJWSDM2amc2ZkNQNw?oc=5", "source_name": "Caixin Global", "published_at": "2022-04-24T07:00:00+00:00", "published_display": "24 Apr 2022 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Global Penny Stocks: Guizhou Yibai Pharmaceutical And 2 More To Watch", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-16T09:15:54+00:00", "published_display": "16 Jul 2026 09:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yibai Pharmaceutical reported revenue of 1.863 billion yuan in 2025, a year-on-year decrease of 14.31%. The company incurred a net loss attributable to shareholders of 330 million yuan, while the gross profit margin increased to 59.65%.", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOMG1XN0hTM2FiVVpXU2U5OGMxVUN1bTg0TUdSQ0VCTGxHck5wbm1XTDZjOFZ1UjdZdzdzMEVlczNVRU50WjN4ekxfR1J2VlY2Uno4NFZFd0pzeG0tekdWX3lBaUZJdWZFNWpOa2FuTU01MFYzMndkY0o1TmgxelBDTG5pS2ROZjl1OFJmenpfWGp6RFB4N3laM3JEbENDYWk5Q0Via1ZB?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-15T00:37:16+00:00", "published_display": "15 Jul 2026 00:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EBIT per share of Guizhou Yibai Pharmaceutical Co. Ltd. Class A \u2013 SSE:600594", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQV0cyS3VNV1Bkell3b3NQY3daT2FlazNIVlRaV1hxaWVZSmIzNU1zOVFCWm83U3IySEV2S05aUmNVRmMzMG92NnA1cFpWTkZuWTFSTnl6blBMU1ZXUzFOUDdnWVl3MnlkR3JVcDlOZ0gtTjhmNGVuMENKSmRvSVRWZGRwX0EyYVRCZ3NLU2ExTnhBd01EZEhnVVdlQQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-08T14:10:43+00:00", "published_display": "08 Jul 2026 14:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guizhou Yibai Pharmaceutical Co.,Ltd.\u2019s Net Profit Dropped 26.9% in First Quarter of 2022", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNRDI0RmluM192a2FGd3dER2ZYWGRKSVg0RThTTE1laTNiYkdnS0xjTVpmNEpsb3VMVXJMd1lPSTdvdXM1eEhNVERrUzNWREhSMHlKWU4xaXlyZ21yZERCaHQwaGd2RmtlVzhmU05SV0JiUHNHSDBvOHJCWm1JVlZOY2tjRkJabTUyZ3prWV94TW01U3V1bWt6VDBXeDg1SjFEUngtQmt5a2MwaUlYaU5JTmxZUm9EU2o1WmFyV2s1V1RGRWhETXA2ZEJWSDM2amc2ZkNQNw?oc=5", "source_name": "Caixin Global", "published_at": "2022-04-24T07:00:00+00:00", "published_display": "24 Apr 2022 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 45, "total_relevant": 4, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 3, "score": 53, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 62, "events": [{"event": "general", "label": "Market update", "weight": 1.1, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 3.39, "latest_week": "2026-07-17", "one_week_move": 2.1, "four_week_move": 9.0, "twelve_week_move": -21.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.157519, "market_dynamics_buy_signal": false, "relative_strength": -12.367452, "fair_value_gap": -18.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 44.6422, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.1% over one week, +9.0% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "simplywall.st", "count": 1}, {"label": "\u5bcc\u9014\u725b\u725b", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "Caixin Global", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 2}, {"label": "Earnings", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "62/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.1% over one week, +9.0% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Global Penny Stocks: Guizhou Yibai Pharmaceutical And 2 More To Watch"}], "updated_at": "2026-07-22T00:59:40.986405+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}